Why the study?
Does intravenous bupivacaine alter cardiac electrophysiology and hemodynamics in pentobarbital-anesthetized dogs?
Does intravenous bupivacaine alter cardiac electrophysiology and hemodynamics in pentobarbital-anesthetized dogs?
Bupivacaine at plasma levels around 2000 ng/ml alters cardiac electrophysiology and decreases left ventricular inotropy in dogs, potentially increasing susceptibility to reentrant arrhythmias.
Answers are grounded in this paper and cite their sources.
Bupivacaine >1000 ng/ml may impair conduction and inotropy in dogs; leaves open human safety thresholds.
To investigate electrophysiologic and hemodynamic responses to various plasma levels of bupivacaine, especially those in the range normally seen during regional anesthesia, bupivacaine was given intravenously as a bolus dose followed by continuous infusion in pentobarbital-anesthetized dogs. Cardiac electrophysiology was studied by His bundle electrography, programmed electrical stimulation, and monophasic action potential recordings. At plasma bupivacaine concentrations below 1000 ng/ml, no significant electrophysiologic or hemodynamic effects were observed. This indicates that systemic responses to absorbed bupivacaine do not contribute to the cardiac electrophysiologic effects recently demonstrated during thoracic epidural analgesia. At a plasma level of about 2000 ng/ml, a level occasionally achieved during regional anesthesia, bupivacaine prolonged impulse conduction time in all parts of the heart, prolonged atrial and AV nodal refractoriness, decreased left ventricular inotropy, but had no effect on ventricular refractoriness or monophasic action potential duration. These electrophysiologic effects may enhance susceptibility to reentrant arrhythmias.
No takes yet. Share an insight, caveat, or question.
Hotvedt et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: